findmyKOL
Clinical trialNCT01608724CompletedPhase 4Interventional

The Efficacy and Safety Study in Patients With Type 2 Diabetes Mellitus

SponsorAstraZenecaEnrollment2,165Diabetes Mellitus, Non-Insulin-Dependent
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

37 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China
  • Research Site

    Baotou, China

  • Research Site

    Beijing, China

  • Research Site

    Benxi, China

  • Research Site

    Changchun, China

  • Research Site

    Chengdu, China

  • Research Site

    Chongqing, China

  • Research Site

    Dalian, China

  • Research Site

    Dongguan, China

  • Research Site

    Foshan, China

  • Research Site

    Fuzhou, China

  • Research Site

    Guangzhou, China

  • Research Site

    Guiyang, China

  • Research Site

    Haikou, China

  • Research Site

    Hangzhou, China

  • Research Site

    Hhht, China

  • Research Site

    Hubei, China

  • Research Site

    Jimo, China

  • Research Site

    Jinan, China

  • Research Site

    Kunming, China

  • Research Site

    Linyi, China

  • Research Site

    Nanjing, China

  • Research Site

    Nantong, China

  • Research Site

    Qingdao, China

  • Research Site

    Shanghai, China

  • Research Site

    Shantou, China

  • Research Site

    Shenyang, China

  • Research Site

    Shiyan, China

  • Research Site

    Suzhou, China

  • Research Site

    Taiyuan, China

  • Research Site

    Tianjin, China

  • Research Site

    Wenzhou, China

  • Research Site

    Wuhan, China

  • Research Site

    Wuxi, China

  • Research Site

    Xi'an, China

  • Research Site

    Zhanjiang, China

  • Research Site

    Zhengzhou, China

  • Research Site

    Ürümqi, China

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Nov 2012
Primary completion
31 May 2014
Completion
31 May 2014
Last update posted
2 Feb 2016
Registered enrollment
2,165
Registry id
NCT01608724

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.